相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior
Anna Spada et al.
NEUROENDOCRINOLOGY (2022)
Overview of the 2022 WHO Classification of Pituitary Tumors
Sylvia L. Asa et al.
ENDOCRINE PATHOLOGY (2022)
Current medical treatment and perspective in gonadotroph tumors
Naomi Even-Zohar et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
AIP: A double agent? The tissue-specific role of AIP as a tumour suppressor or as an oncogene
Oliver Haworth et al.
BRITISH JOURNAL OF CANCER (2022)
Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma
Yona Greenman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway
Richard A. Hickman et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a-5p
Jianhua Cheng et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms
Vinaya Srirangam Nadhamuni et al.
ENDOCRINE REVIEWS (2020)
Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
Mirela Diana Ilie et al.
CANCERS (2020)
Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution
Alexander F. Haddad et al.
NEUROSURGICAL FOCUS (2020)
CYCLIN-B1/2 and-D1 act in opposition to coordinate cortical progenitor self-renewal and lineage commitment
Daniel W. Hagey et al.
NATURE COMMUNICATIONS (2020)
Cyclin A in nonfunctioning pituitary adenomas
Elisa B. Lamback et al.
ENDOCRINE (2020)
Clinical and Pathological Aspects of Silent Pituitary Adenomas
Juliana Drummond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
C. Villa et al.
VIRCHOWS ARCHIV (2019)
Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma A Single-Center, Open-Label, 2-Year Randomized Clinical Trial
Rafael L. Batista et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Epidemiology and biomarker profile of pituitary adenohypophysial tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2018)
Upregulation of cyclin B1 plays potential roles in the invasiveness of pituitary adenomas
Peng Zhao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas
Mark Gruppetta et al.
PITUITARY (2017)
Overview of the 2017 WHO Classification of Pituitary Tumors
Ozgur Mete et al.
ENDOCRINE PATHOLOGY (2017)
Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists
Y. Greenman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors
Paula Muessnich et al.
CELL CYCLE (2015)
Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy
Leonardo Vieira Neto et al.
CLINICAL ENDOCRINOLOGY (2015)
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
Hiroshi Nishioka et al.
ENDOCRINE PATHOLOGY (2015)
Functioning Gonadotroph Adenomas
Georgia Ntali et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers et al.
ENDOCRINE REVIEWS (2013)
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
Marie-Lise Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2013)
NR5A2 Regulates Lhb and Fshb Transcription in Gonadotrope-Like Cells In Vitro, but Is Dispensable for Gonadotropin Synthesis and Fertility In Vivo
Jerome Fortin et al.
PLOS ONE (2013)
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
Giampaolo Trivellin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
Leandro Kasuki Jomori de Pinho et al.
NEUROENDOCRINOLOGY (2011)
Cyclins and their related proteins in pituitary tumourigenesis
Madalina Musat et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
D. Dworakowska et al.
ENDOCRINE-RELATED CANCER (2009)
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
Marie-Lise Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2009)
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas
Chrysanthia A. Leontiou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Differential expression of neurogenins and NeuroD1 in human pituitary tumours
A. Fratticci et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas
H Nakabayashi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas
DJ Simpson et al.
CARCINOGENESIS (2001)
Cyclin D and cyclin E expression in normal and adenomatous pituitary
S Jordan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Approaches to define the role of SF-1 at different levels of the hypothalamic pituitary-steroidogenic organ axis
M Bakke et al.
ENDOCRINE RESEARCH (2000)
分享论文
